- Citations, last 5 years
- 2 490
- Works, last 5 years
- 440
- h-index
- 112
- Scientists listed
- 28
- Grants since 2016
- 3 213
Grants received
2021–2025 · research · R01
Ceramide-Rich Platforms Functionalize Gemcitabine Uptake
Richard N Kolesnick · Kettering University · funded by National Institutes of Health
2021–2026 · research · R35
Chemical and Physical Mechanisms of Wound Detection
Philipp Michael Niethammer · Kettering University · funded by National Institutes of Health
2021–2027 · research · R01
HCMV-induced innate-like CD8 T cells and allogeneic HCT outcome
Katharine C Hsu · Kettering University · funded by National Institutes of Health
2021–2026 · career development · K08
Uncovering Epigenetic and Transcriptional Drivers of Neuroendocrine Plasticity at Single-Cell Level in Patients with Small Cell Lung Cancer Transformation
Joseph Minhow Chan · Kettering University · funded by National Institutes of Health
2021–2026 · cooperative agreement · U01
Impact of the aging niche on cancer phenotypes probed using mouse cancer models produced by somatic engineering.
Scott W. Lowe · Kettering University · funded by National Institutes of Health
2021–2026 · career development · K08
Investigating the contribution of cellular senescence to the efficacy of radiation therapy.
Paul Bernard Romesser · Kettering University · funded by National Institutes of Health
2021–2027 · training · T32
Molecular Imaging in Cancer Biology Training Program
Jason S. Lewis · Kettering University · funded by National Institutes of Health
2021–2026 · research · R01
Transcriptional control of NK cell metabolism
Joseph Chai-Yuen Sun · Kettering University · funded by National Institutes of Health
2021–2027 · research · R01
Impact of sex differences on the trajectory of interactome dysfunctions across the AD spectrum
Gabriela Chiosis · Kettering University · funded by National Institutes of Health
2021–2027 · research · R01
Directing Fate, Subtype Identity and Survival in Human Pluripotent-Derived Midbrain Dopamine Neurons
Doron Betel · Kettering University · funded by National Institutes of Health
2021–2026 · program · P50
The Memorial Sloan Kettering Cancer Center SPORE in Leukemia
Omar Abdel-Wahab · Kettering University · funded by National Institutes of Health
2021–2027 · career development · K08
Behavioral Activation for Depression in Older Adult Cancer Survivors: Pilot Randomized Control Trial and Implementation Outcomes
Rebecca Saracino · Kettering University · funded by National Institutes of Health
2021–2026 · research · R37
Molecular mechanisms of T cell responses to a clonal neoantigen resulting from a mutated driver oncogene.
Christopher Austin Klebanoff · Kettering University · funded by National Institutes of Health
2021–2028 · research · R35
Novel therapeutic development for small cell lung cancer
Charles M. Rudin · Kettering University · funded by National Institutes of Health
2021–2026 · cooperative agreement · U01
Genomic control of gene regulatory networks governing early human lineage decisions
Michael A Beer · Kettering University · funded by National Institutes of Health
2021–2027 · research · R01
Drivers of histologic transformation in EGFR-mutant lung cancer
Charles M. Rudin · Kettering University · funded by National Institutes of Health
2021–2026 · research · R01
Targeting immune suppressive microenvironment in ATC
James A Fagin · Kettering University · funded by National Institutes of Health
2021–2026 · research · R01
Redox control of the NLRP1 inflammasome
Daniel Bachovchin · Kettering University · funded by National Institutes of Health
2021–2027 · research · R01
Characterizing and Targeting BAX- and BAK-Dependent Cell Death in Cancer
Emily H Cheng · Kettering University · funded by National Institutes of Health
2021–2027 · research · R01
Chaperome networks in Alzheimer's disease
Ottavio Arancio · Kettering University · funded by National Institutes of Health
2021–2027 · research · R01
PSMA’s enzymatic activity as new target for Prostate Cancer diagnosis and therapy
Brett Stewart Carver · Kettering University · funded by National Institutes of Health
2021–2026 · cooperative agreement · U01
Pediatric Preclinical In Vivo Testing Center for Pediatric Sarcoma and Other Solid Tumors
Filemon S Dela Cruz · Kettering University · funded by National Institutes of Health
2021–2026 · research · R01
Real-time MRI-guided adaptive radiotherapy of unresectable pancreatic cancer
Ricardo Otazo · Kettering University · funded by National Institutes of Health
2021–2025 · research · R01
Mechanisms of lysosomal ion transport proteins involved in pH homeostasis
Richard Kevin Hite · Kettering University · funded by National Institutes of Health
2021–2026 · research · R01
Improving efficacy of radioiodine treatment of thyroid cancer
James A Fagin · Kettering University · funded by National Institutes of Health
2021–2026 · cooperative agreement · U01
Understanding and targeting MAPK pathway activation in NF1-deficient malignant peripheral nerve sheath tumor (MPNST)
Ping Chi · Kettering University · funded by National Institutes of Health
2021–2027 · research · R01
Empathic Communication Skills Training to Reduce Lung Cancer Stigma
Smita Banerjee · Kettering University · funded by National Institutes of Health
2021–2027 · research · R01
Predicting sensitivity and resistance in RET-driven cancers
Alexander Drilon · Kettering University · funded by National Institutes of Health
2021–2026 · research · R01
Genetic susceptibility to Barrett's esophagus: From GWAS to biology
Matthew Frank Buas · Kettering University · funded by National Institutes of Health
2021–2027 · cooperative agreement · U01
Deciphering the Genomics of Gene Network Regulation of T Cell and Fibroblast States in Autoimmune Inflammation
Christina S Leslie · Kettering University · funded by National Institutes of Health
2021–2026 · research · R01
Macrophages as modulators of T cell function and therapeutic response in clear cell renal cell carcinoma
Abraham Ari Hakimi · Kettering University · funded by National Institutes of Health
2021–2027 · research · R37
Molecular Pathogenesis and Therapy of Systemic Histiocytic Neoplasms
Eli Lous Diamond · Kettering University · funded by National Institutes of Health
2021–2026 · career development · K08
A Targeted Approach to the Surveillance of Precursor Lesions for Gastric Cancer
Monika Laszkowska · Kettering University · funded by National Institutes of Health
2021–2026 · career development · K08
A multi-faceted intervention to promote breast cancer hormone receptor testing in Tanzania
Dianna L. Ng · Kettering University · funded by National Institutes of Health
2021–2027 · research · R35
Sizing and Scaling in Functional Muscle Cells
Mary K Baylies · Kettering University · funded by National Institutes of Health
2021–2026 · cooperative agreement · U24
The MSK Genomic Data Analysis Center for Tumor Evolution
Nikolaus Schultz · Kettering University · funded by National Institutes of Health
2021–2027 · career development · K00
Dissecting mechanisms of inflammation driven cancer susceptibility in epithelial barrier tissues
Christopher Cowley · Kettering University · funded by National Institutes of Health
2021–2026 · program · P50
Project 2: Defining and exploiting genetic dependencies in complex karyotype AML
Scott W. Lowe · Kettering University · funded by National Institutes of Health
2021–2026 · program · P50
Project 1: Increasing therapeutic efficacy in isocitrate dehydrongenase (IDH)–mutant acute myeloid leukemia (AML)
Ross L Levine · Kettering University · funded by National Institutes of Health
2021–2026 · program · P50
Project 2: Defining and exploiting genetic dependencies in complex karyotype AML
Scott W. Lowe · Kettering University · funded by National Institutes of Health